X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2024-01-16 | ADAP | Rawcliffe Adrian | CEO | S - Sale | $0.70 | -39,384 | 44,848 | -47% | -$27,594 | |||||
| M | 2024-01-16 | ADAP | Norry Elliot | Chief Medical Officer | S - Sale | $0.69 | -20,563 | 19,257 | -52% | -$14,106 | |||||
| M | 2024-01-16 | ADAP | Lunger John | Chief Patient Supply Officer | S - Sale | $0.70 | -22,795 | 19,015 | -55% | -$15,889 | |||||
| M | 2024-01-16 | ADAP | Bertrand William C Jr | COO | S - Sale | $0.70 | -23,589 | 20,201 | -54% | -$16,423 | |||||
| M | 2024-01-11 | ADAP | Norry Elliot | Chief Medical Officer | S - Sale | $0.85 | -11,808 | 11,841 | -50% | -$10,015 | |||||
| M | 2024-01-11 | ADAP | Bertrand William C Jr | COO | S - Sale | $0.85 | -9,229 | 7,874 | -54% | -$7,813 | |||||
| M | 2024-01-11 | ADAP | Rawcliffe Adrian | CEO | S - Sale | $0.85 | -29,202 | 26,388 | -53% | -$24,734 | |||||
| M | 2024-01-11 | ADAP | Lunger John | Chief Patient Supply Officer | S - Sale | $0.85 | -9,229 | 7,874 | -54% | -$7,813 | |||||
2023-09-01 | ADAP | Rawcliffe Adrian | CEO | S - Sale | $0.78 | -2,403 | 3,449 | -41% | -$1,874 | ||||||
2023-08-01 | ADAP | Lunger John | Chief Patient Supply Officer | S - Sale | $0.91 | -3,096 | 4,718 | -40% | -$2,804 | ||||||
2023-07-10 | ADAP | Menzel Garry E | Dir | S - Sale | $0.91 | -47,702 | 75,056 | -39% | -$43,447 | ||||||
2023-06-27 | ADAP | Rawcliffe Adrian | CEO | S - Sale | $0.92 | -2,333 | 3,519 | -40% | -$2,146 | ||||||
2023-01-31 | ADAP | Piccina Cintia | Chief Commercial Officer | S - Sale | $1.87 | -11,890 | 19,535 | -38% | -$22,230 | ||||||
2023-01-17 | ADAP | Lunger John | Chief Patient Supply Officer | S - Sale | $1.86 | -4,440 | 7,264 | -38% | -$8,250 | ||||||
2023-01-17 | ADAP | Bertrand William C Jr | COO | S - Sale | $1.86 | -4,440 | 7,264 | -38% | -$8,250 | ||||||
2023-01-17 | ADAP | Norry Elliot | Chief Medical Officer | S - Sale | $1.86 | -2,159 | 3,491 | -38% | -$4,011 | ||||||
2023-01-17 | ADAP | Rawcliffe Adrian | CEO | S - Sale | $1.86 | -10,057 | 13,351 | -43% | -$18,686 | ||||||
| M | 2023-01-11 | ADAP | Bertrand William C Jr | COO | S - Sale | $1.72 | -8,816 | 8,121 | -52% | -$15,197 | |||||
| M | 2023-01-11 | ADAP | Lunger John | Chief Patient Supply Officer | S - Sale | $1.72 | -8,816 | 8,121 | -52% | -$15,197 | |||||
| M | 2023-01-11 | ADAP | Norry Elliot | Chief Medical Officer | S - Sale | $1.72 | -11,292 | 12,191 | -48% | -$19,421 | |||||
| M | 2023-01-11 | ADAP | Rawcliffe Adrian | CEO | S - Sale | $1.72 | -31,805 | 24,882 | -56% | -$54,791 | |||||
2023-01-04 | ADAP | Bertrand William C Jr | COO | S - Sale | $1.69 | -3,584 | 5,781 | -38% | -$6,071 | ||||||
2023-01-04 | ADAP | Lunger John | Chief Patient Supply Officer | S - Sale | $1.69 | -1,100 | 1,725 | -39% | -$1,863 | ||||||
2023-01-04 | ADAP | Norry Elliot | Chief Medical Officer | S - Sale | $1.69 | -876 | 1,361 | -39% | -$1,484 | ||||||
2023-01-04 | ADAP | Rawcliffe Adrian | CEO | S - Sale | $1.69 | -5,073 | 6,631 | -43% | -$8,594 | ||||||
2022-09-01 | ADAP | Rawcliffe Adrian | CEO | S - Sale | $1.97 | -2,536 | 3,316 | -43% | -$4,993 | ||||||
2022-08-01 | ADAP | Lunger John | Chief Patient Supply Officer | S - Sale | $1.77 | -2,983 | 4,829 | -38% | -$5,290 | ||||||
2022-08-01 | ADAP | Piccina Cintia | Chief Commercial Officer | S - Sale | $1.77 | -21,040 | 34,824 | -38% | -$37,314 | ||||||
2022-07-05 | ADAP | Lunger John | Chief Patient Supply Officer | S - Sale | $1.68 | -1,973 | 3,104 | -39% | -$3,311 | ||||||
2022-06-27 | ADAP | Rawcliffe Adrian | CEO | S - Sale | $1.63 | -2,562 | 3,290 | -44% | -$4,176 | ||||||
2022-05-20 | ADAP | Wood Gavin | CFO | P - Purchase | $0.29 | +39,000 | 96,000 | +68% | +$11,326 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |